跳至主要内容
临床试验/CTRI/2024/04/066176
CTRI/2024/04/066176尚未招募3 期

Pharmacognostical, Phytochemical analysis of Mamajjaka (Enicostemma littorale Blume) and its clinical evaluation in Dyslipidemia (Medodushti) - NI

Ch Brahm Prakash Ayurved Charak Sansthan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with total cholesterol above 200mg/dl or patients with triglycerides above 150 mg/dl or HDL below 50 mg/dl in females and below 40 mg/dl in males or LDL above 130mg/dl, Diagnosed and confirmed patients of dyslipidemia based on investigation, Patients with one or more lakshana of Medodushti, Patients who are ready to give consent with home address and contact number, Patients who are ready to give consent with home address and contact number, Patients ready to take orally powdered medicine

排除标准

  • Patient below 18 years and above 60 years of age.
  • Patient having illness like Tuberculosis, Carcinoma, or major illness like renal or Liver disorders.
  • Patients having uncontrolled Diabetes mellitus (RBS above 300 mg per dl) and Hypertension (BP above 140/90 mm per hg).
  • Patient having past-history of heart problem like Myocardial Infarction, Unstable angina, and congestive cardiac failure.
  • Pregnant females and lactating mothers.

研究者

发起方
Ch Brahm Prakash Ayurved Charak Sansthan

相似试验